Updated: May 19, 2026

Andrew Hirsch

CCCCC4 Therapeutics, Inc.SEC CIK: 0001586707
Estimated Net Worth
$4.83 Million0.0%vs Last Year
Last Updated: May 19, 2026 11:41 PM EST

Transaction Summary

Total Transactions43
Buy-Sell Ratio
Buy Transactions1
Sell Transactions0

Transaction Volume

Total Volume$84.00K
Net Volume$84.00K
Buy Volume$84.00K
Sell Volume$0.00

Trade Analysis

AVG Trade Size-$18.36K
Largest Trade$84.00K
Most Active MonthFeb
Most Active Year2020

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Andrew Hirsch has an estimated net worth of $4.83 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., BIND Therapeutics, Inc, Editas Medicine, Inc., and C4 Therapeutics, Inc..



2020 was Andrew Hirsch's most active year for acquiring shares with 8 total transactions. Andrew Hirsch's most active month to acquire stocks was the month of January. 2020 was Andrew Hirsch's most active year for disposing of shares, totalling 8 transactions. Andrew Hirsch's most active month to dispose stocks was the month of January. 2022 saw Andrew Hirsch paying a total of $84,000.00 for 135,000 shares, this is the most they've acquired in one year. In 2019 Andrew Hirsch cashed out on 23,126 shares for a total of $288,237.73, their largest year based on trade value.

Holdings & Transactions

CCCCc4 therapeutics, inc.
President & CEO Director
Updated: Feb 18, 2026VIEW QUOTE
Form TypeSEC Filing
0.30753.91K$1.89-$91.12K3.28MFeb 13 - 15View
2.42536.58K$3.18-$70.65K758.45KFeb 14 - 15View
-0.025.55K$6.04-$33.52K256.86KNov 07View
-0.013.33K$6.36-$21.17K262.41KSep 16View
-0.036.56K$7.90-$51.82K210.74KFeb 15View
4.99568.90K682.80KFeb 14View
489.60K489.60KSep 18View
-0.012.21K$2.93-$6.46K168.90KAug 30View
16.62448.80K475.81KFeb 15View
-0.054.32K$7.78-$33.60K89.51KJan 30View
-0.163.67K$7.01-$25.76K18.83KMay 26View
97.50KMay 25View
10.00K$8.40$84.00K10.00KApr 12View
87.50K87.50KFeb 23View
1.69M1.69MOct 01View
View
EDITeditas medicine, inc.
Updated: Jun 10, 2025VIEW QUOTE
Form TypeSEC Filing
37.50K37.50KJun 06View
25.00K25.00KMay 30View
25.00K25.00KJun 01View
25.00K25.00KJun 09View
11.54K11.54KJun 03View
11.54K11.54KJun 10View
11.54K11.54KJun 12View
11.54K11.54KJun 15View
23.08K23.08KMay 30View
2.00KView
AGIOagios pharmaceuticals, inc.
Chief Financial Officer Officer
Updated: Apr 24, 2020VIEW QUOTE
Form TypeSEC Filing
-0.051.93K$45.91-$88.47K36.06KApr 22View
-0.051.60K$40.64-$64.98K31.08KApr 13 - 14View
-0.041.06K$48.66-$51.38K23.19KFeb 22 - 24View
3.1456.11K$52.01-$46.08K73.99KFeb 14 - 18View
17.68K17.68KApr 22View
50.00K50.00KFeb 22View
-0.04821.00$58.03-$47.64K17.87KFeb 16 - 19View
-0.304.55K$52.82-$240.60K10.45KJan 20 - 22View
15.00K15.00KJul 20View
41.25K41.25KFeb 16View
47.60K47.60KFeb 21View
125.00K125.00KSep 20View
View
bind therapeutics, inc
PRESIDENT & CEO Director
Updated: Jun 23, 2015
Form TypeSEC Filing
20.00K20.00KJun 22View
140.00K140.00KMar 07View
45.00K45.00KMar 11View
31.29KView